Results for: Todd Kuiken
Todd Kuiken Senior Research Scholar; GES Center Executive Committee Member Genetic Engineering and Society Center Contact Email: firstname.lastname@example.org | Phone: (919) 515-2593 | Twitter: @drtoddoliver | CV Bio Dr. Todd Kuiken’s work explores the scientific and…
GES Colloquium, 9/10/19 | Dr. Todd Kuiken will provide an update on major international treaties and discussions around synthetic biology, and ways for NC State and the broader synbio community to participate in these activities.
CRISPR and RISK – A Critical Discussion of Gene Editing; Rochester Institute of Technology, Feb 26, 2019. Speakers: Stephen Hilgartner, Cornell University, Department of Science and Technology Studies; Todd Kuiken, Senior Research Scholar, Genetic Engineering and Society Center North Carolina State University; Patti Durr, RIT/NTID, Department of Cultural and Creative Studies
Innovative Genomics Institute, UC Berkeley, Jan 22, 2019 | Todd Kuiken Seminar: Governance of Emerging Biotechnologies in a World Without Borders. As synthetic biology, genome editing, gene drives, CRISPR, and the biotechnologies of tomorrow continue to emerge, international treaties are struggling to keep pace. While recognizing that biotechnologies are rapidly developing, with potential benefits and potential adverse impacts; how will treaties develop governance systems to both enable benefits while preventing or minimizing adverse effects? How do international treaties that address access and benefits sharing agreements based on “physical genetic material” incorporate (or not) digital sequence information? If engineered gene drives do not recognize a country’s or indigenous community’s sovereign lands; how does the international community address a situation where one country decides to move forward while another, or indigenous community, says no? And how does the International Union for Conservation of Nature, the global authority on the status of the natural world and the measures needed to safeguard it, incorporate (or not), the tools of biotechnology? These are just some of the complicated questions international treaties have been debating over the last 10 years. Join us for a discussion as I examine these and other issues through my personal experiences inside these debates.
RSVP at https://www.meetup.com/BosLab/events/247749349/Hosted by @Boslab | Boston Open Science Laboratory <span style="color: rgb(46
Join us in our regular Colloquium space, room 129 in the 1911 Building, to listen to and discuss Todd’s interview on WUNC. BYO Lunch! Livestream: http://wunc.org/programs/state-things#stream/0→ GES Scholar Dr. Todd Kuiken will join Frank Stasio…
They say that necessity is the mother of invention. Many would argue that their greatest necessity is health. So what happens when treatments are ineffective or unavailable? Today, in the age of crowdfunding, some people are taking matters into their own hands and developing their own treatments, including surgical techniques, gene therapies and molecular therapies.
GES Senior Research Scholar Dr. Todd Kuiken, together with international science policy expert Eleonore Pauwels, of The Wilson Center, explores the risks, regulatory issues, and implications of the emerging DIY, “patient-powered” health research movement in the Spring 2017 issue of BioCoder.
GES Research Scholar Dr. Todd Kuiken has concerns about DARPA, who’s investments are “bending the entire field of synthetic biology towards military applications.” Will DARPA’s initiatives lead to the militarization of the natural environment?